Newsroom

2018

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

NTD evaluation cover

USAID Neglected Tropical Diseases Program 2016 Evaluation

04/10/2018

In recognition of the 10-year anniversary of the USAID NTD program, the Agency commissioned an independent evaluation to better understand how the program has contributed to achieving the World Health Organization (WHO) 2020 NTD goals and inform the future direction of the Agency NTD Program.

 

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

2017

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

2016

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

2015

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

2014

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

07/25/2018
USAID logo

USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.